234
Participants
Start Date
January 1, 2021
Primary Completion Date
October 31, 2023
Study Completion Date
October 31, 2023
combined diagnosis of renal parenchymal damage
"This study is an observational study to evaluate the accuracy of renal parenchymal damage combined diagnosis with no intervention. All patients from the cohort accept MRI-DWI scan,the urinary biomarkers detection, disease gene detection and DMSA scan.~1. This combined diagnosis includes MRI-DWI scan and the urinary biomarkers detection.~ MRI-DWI: All the scans are performed using the MagnetomVerio 3.0T magnetic resonance imaging system from Siemens.~ Urinary polypeptide collection: Urine samples requirements: volume between 50-100ml, specific gravity \>1.010. Immunomagnetic beads isolation technique is used to collect polypeptide.~2. The reference standard is DMSA scan: Intravenous injection of 99mTC-DMSA5mCi is followed by anterior and posterior planar imaging of the renal area 1 hour later. The DMSA scan images are read by 2 trained radiologists and confirmed by the special doctor of the center for diagnosis and treatment of renal and urinary diseases at the same time."
Children's Hospital of Fudan University, Shanghai
Children's Hospital of Fudan University
OTHER